SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The development of health technology assessment
4 references·16 citing·47 second hop
The development of health technology assessment (2003)The development of health technology asse…The New Industrial State (2007)The New Industrial StateCochrane Collaboration Handbook (1996)Cochrane Collaboration Handbo…Structural adjustment and health (1995)Structural adjustment and hea…Effectiveness and Efficiency (1994)Effectiveness and EfficiencyTreatment with psychedelics is psychotherapy: beyond reductionism (2023)Treatment with psychedelics i…Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries (2021)Similarities and Differences …Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Using health technology asses…Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries (2016)Why do health technology asse…The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization (2015)The “Efficacy-Effectiveness G…Eliciting ethical and social values in health technology assessment: A participatory approach (2011)Eliciting ethical and social …Patient reported outcomes: looking beyond the label claim (2010)Patient reported outcomes: lo…What is technology assessment? (2009)What is technology assessment?Development of a toolkit and glossary to aid in the adaptation of health technology assessment (HTA) reports for use in different contexts (2009)Development of a toolkit and …Developing Health Technology Assessment to address health care system needs (2009)Developing Health Technology …Ethical analysis to improve decision-making on health technologies (2008)Ethical analysis to improve d…Public Policy and the Challenge of Chronic Noncommunicable Diseases (2007)Public Policy and the Challen…Patient-based health technology assessment: A vision of the future (2007)Patient-based health technolo…Coverage with Evidence Development: An examination of conceptual and policy issues (2007)Coverage with Evidence Develo…Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems) (2006)Framework for describing and …Future Directions in Evaluation Research: People, Organizational, and Social Issues (2004)Future Directions in Evaluati…Economic Growth in a Cross Section of Countries (1989)Economic Reform and the Process of Global Integration (1995)Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study (1997)Global public health: a scorecard (2008)What can global health institutions do to help strengthen health systems in low income countries? (2010)Priorities for developing countries in the global response to non-communicable diseases (2012)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)What is coefficient alpha? An examination of theory and applications. (1993)Assessment of PRO Label Claims Granted by the FDA as Compared to the EMA (2006–2010) (2013)Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review (2015)Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation (1999)BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY ASSESSMENTS (2002)Incremental cost-effectiveness ratios (ICERs): The silence of the lambda (2005)Integrating patients' views into health technology assessment: Analytic hierarchy process (AHP) as a method to elicit patient preferences (2011)Patients’ preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis (2012)A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme (2004)Coverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’ (2006)Expected value of information and decision making in HTA (2006)Dangerous omissions: the consequences of ignoring decision uncertainty (2010)Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development (2012)Managed Entry Agreements: Policy Analysis From the European Perspective (2020)Technology and man's future (1981)Technology Assessment (2005)HEALTH TECHNOLOGY ASSESSMENT, VALUE-BASED DECISION MAKING, AND INNOVATION (2013)Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA (2018)Administrative Data Linkage in Brazil: Potentials for Health Technology Assessment (2019)Can it work? Does it work? Is it worth it? (1999)Qualitative research in health care: Assessing quality in qualitative research (2000)Appraising qualitative research for inclusion in systematic reviews: a quantitative and qualitative comparison of three methods (2007)Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis (2017)Opportunities and challenges in using real-world data for health care (2020)A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) (2015)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework (2017)Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward (2019)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)Immigrant Enclaves: An Analysis of the Labor Market Experiences of Cubans in Miami (1980)Conclusion: epistemic communities, world order, and the creation of a reflective research program (1992)Famine, Affluence, and Morality (2018)Educational Research and Teaching: a response to David Hargreaves’ TTA lecture (1997)Measurement and psychotherapy (2000)School-Related Outcomes of Traumatic Event Exposure and Traumatic Stress Symptoms in Students: A Systematic Review of Research from 1990 to 2015 (2016)Meta-analysis of benzodiazepine use in the treatment of insomnia. (2000)A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder (2006)Pharmacotherapy for post traumatic stress disorder (PTSD) (2006)
this work references cited by second hop

References

  • 2007The New Industrial State2,596 cited
  • 1994Effectiveness and Efficiency440 cited
  • 1996Cochrane Collaboration Handbook404 cited
  • 1995Structural adjustment and health27 cited

Cited by

  • 2017Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries306 cited
  • 2007Patient-based health technology assessment: A vision of the future180 cited
  • 2015The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization177 cited
  • 2009What is technology assessment?174 cited
  • 2010Patient reported outcomes: looking beyond the label claim162 cited
  • 2007Public Policy and the Challenge of Chronic Noncommunicable Diseases161 cited
  • 2007Coverage with Evidence Development: An examination of conceptual and policy issues147 cited
  • 2004Future Directions in Evaluation Research: People, Organizational, and Social Issues141 cited
  • 2023Treatment with psychedelics is psychotherapy: beyond reductionism119 cited
  • 2008Ethical analysis to improve decision-making on health technologies104 cited
  • 2006Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems)

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

101 cited
  • 2021Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries93 cited
  • 2009Development of a toolkit and glossary to aid in the adaptation of health technology assessment (HTA) reports for use in different contexts89 cited
  • 2009Developing Health Technology Assessment to address health care system needs87 cited
  • 2011Eliciting ethical and social values in health technology assessment: A participatory approach84 cited
  • 2016Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries82 cited